HEADER PROTEIN BINDING 11-NOV-09 3AA1 TITLE CRYSTAL STRUCTURE OF ACTIN CAPPING PROTEIN IN COMPLEX WITH THE CP- TITLE 2 BINDING MOTIF DERIVED FROM CKIP-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: F-ACTIN-CAPPING PROTEIN SUBUNIT ALPHA-1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CAPZ 36/32, BETA-ACTININ SUBUNIT I; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: F-ACTIN-CAPPING PROTEIN SUBUNIT BETA ISOFORMS 1 AND 2; COMPND 8 CHAIN: B; COMPND 9 SYNONYM: CAPZ B1 AND B2, CAPZ 36/32, BETA-ACTININ SUBUNIT II; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES; COMPND 12 OTHER_DETAILS: BETA TENTACLE DELETION; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: 23MER PEPTIDE FROM PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING COMPND 15 FAMILY O MEMBER 1; COMPND 16 CHAIN: C; COMPND 17 FRAGMENT: CP-BINDING MOTIF, RECIDUES 148-170; COMPND 18 SYNONYM: CKIP-1, CASEIN KINASE 2-INTERACTING PROTEIN 1, C-JUN-BINDING COMPND 19 PROTEIN, OSTEOCLAST MATURATION ASSOCIATED GENE 120 PROTEIN; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 GENE: CAPZA1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA2 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PETDUET1; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 13 ORGANISM_COMMON: CHICKEN; SOURCE 14 ORGANISM_TAXID: 9031; SOURCE 15 GENE: CAPZB; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: ROSETTA2 (DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PETDUET1; SOURCE 21 MOL_ID: 3; SOURCE 22 SYNTHETIC: YES; SOURCE 23 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 24 ORGANISM_COMMON: HUMAN; SOURCE 25 ORGANISM_TAXID: 9606; SOURCE 26 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. KEYWDS ACTIN CAPPING PROTEIN, BARBED END REGULATION, CARMIL FAMILY PROTEIN, KEYWDS 2 CONFORMATIONAL CHANGE, CELL MOTILITY, ACTIN CAPPING, ACTIN-BINDING, KEYWDS 3 CYTOSKELETON, CELL MEMBRANE, TUMOR SUPPRESSOR, PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR S.TAKEDA,S.MINAKATA,A.NARITA,M.KITAZAWA,T.YAMAKUNI,Y.MAEDA,Y.NITANAI REVDAT 1 04-AUG-10 3AA1 0 JRNL AUTH S.TAKEDA,S.MINAKATA,R.KOIKE,I.KAWAHATA,A.NARITA,M.KITAZAWA, JRNL AUTH 2 M.OTA,T.YAMAKUNI,Y.MAEDA,Y.NITANAI JRNL TITL TWO DISTINCT MECHANISMS FOR ACTIN CAPPING PROTEIN JRNL TITL 2 REGULATION--STERIC AND ALLOSTERIC INHIBITION JRNL REF PLOS BIOL. V. 8 E1000 2010 JRNL REFN ISSN 1544-9173 JRNL PMID 20625546 JRNL DOI 10.1371/JOURNAL.PBIO.1000416 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0072 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.36 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 38533 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2049 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2271 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.99 REMARK 3 BIN R VALUE (WORKING SET) : 0.2520 REMARK 3 BIN FREE R VALUE SET COUNT : 128 REMARK 3 BIN FREE R VALUE : 0.3660 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4304 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 379 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.24000 REMARK 3 B22 (A**2) : -1.28000 REMARK 3 B33 (A**2) : 2.52000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.207 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.181 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.129 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.350 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.910 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4511 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6126 ; 1.528 ; 1.958 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 560 ; 5.842 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 233 ;36.919 ;24.635 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 798 ;16.141 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 32 ;18.572 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 661 ; 0.107 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3472 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2709 ; 1.006 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4400 ; 1.782 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1802 ; 2.525 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1712 ; 4.033 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3AA1 COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 13-NOV-09. REMARK 100 THE RCSB ID CODE IS RCSB028999. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL26B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU JUPITER 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40661 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.05900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.6600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.26100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.410 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1IZN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 17.5% PEG 400, 30MM BACL2, 100MM MES- REMARK 280 NAOH, PH 6.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.65750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 68.33300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.14900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 68.33300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.65750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.14900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ORIGOMETRIC STATE OF THE ACTIN CAPPING PROTEIN IS A REMARK 300 HETERO DIMER COMPOSE OF SUBUNIT A (CHAIN A) AND SUBUNIT B (CHAIN B) REMARK 300 IN VIVO AND IN VITRO. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ASP A 3 REMARK 465 PHE A 4 REMARK 465 GLU A 5 REMARK 465 ASP A 6 REMARK 465 LYS A 278 REMARK 465 ILE A 279 REMARK 465 GLY A 280 REMARK 465 LYS A 281 REMARK 465 GLU A 282 REMARK 465 MET A 283 REMARK 465 GLN A 284 REMARK 465 ASN A 285 REMARK 465 ALA A 286 REMARK 465 MET B 1 REMARK 465 SER C 148 REMARK 465 GLY C 170 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 48 -73.38 -92.76 REMARK 500 ILE A 148 -60.41 -96.66 REMARK 500 TYR A 199 26.64 -143.80 REMARK 500 SER A 219 -112.38 -121.65 REMARK 500 THR A 253 -85.83 -117.12 REMARK 500 ASP B 85 48.45 -150.14 REMARK 500 SER B 161 -64.16 -156.83 REMARK 500 HIS C 152 72.18 -119.63 REMARK 500 ARG C 164 -89.34 -26.02 REMARK 500 ARG C 165 96.70 112.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 412 DISTANCE = 5.21 ANGSTROMS REMARK 525 HOH A 447 DISTANCE = 6.32 ANGSTROMS REMARK 525 HOH A 448 DISTANCE = 8.07 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES A 287 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES A 288 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IZN RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN APO-FORM REMARK 900 RELATED ID: 3AA0 RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEXED WITH THE 21 AA LENGTH CARMIL REMARK 900 FRAGMENT REMARK 900 RELATED ID: 3AA6 RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEXED WITH THE 23 AA LENGTH CD2AP REMARK 900 FRAGMENT REMARK 900 RELATED ID: 3AA7 RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN APO-FORM REMARK 900 RELATED ID: 3AAA RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEXED WITH V-1 REMARK 900 RELATED ID: 3AAE RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEXED WITH THE 32 AA LENGTH CARMIL REMARK 900 FRAGMENT DBREF 3AA1 A 1 286 UNP P13127 CAZA1_CHICK 1 286 DBREF 3AA1 B 1 244 UNP P14315 CAPZB_CHICK 1 244 DBREF 3AA1 C 148 170 UNP Q53GL0 PKHO1_HUMAN 148 170 SEQRES 1 A 286 MET ALA ASP PHE GLU ASP ARG VAL SER ASP GLU GLU LYS SEQRES 2 A 286 VAL ARG ILE ALA ALA LYS PHE ILE THR HIS ALA PRO PRO SEQRES 3 A 286 GLY GLU PHE ASN GLU VAL PHE ASN ASP VAL ARG LEU LEU SEQRES 4 A 286 LEU ASN ASN ASP ASN LEU LEU ARG GLU GLY ALA ALA HIS SEQRES 5 A 286 ALA PHE ALA GLN TYR ASN MET ASP GLN PHE THR PRO VAL SEQRES 6 A 286 LYS ILE GLU GLY TYR ASP ASP GLN VAL LEU ILE THR GLU SEQRES 7 A 286 HIS GLY ASP LEU GLY ASN GLY ARG PHE LEU ASP PRO ARG SEQRES 8 A 286 ASN LYS ILE SER PHE LYS PHE ASP HIS LEU ARG LYS GLU SEQRES 9 A 286 ALA SER ASP PRO GLN PRO GLU ASP THR GLU SER ALA LEU SEQRES 10 A 286 LYS GLN TRP ARG ASP ALA CYS ASP SER ALA LEU ARG ALA SEQRES 11 A 286 TYR VAL LYS ASP HIS TYR PRO ASN GLY PHE CYS THR VAL SEQRES 12 A 286 TYR GLY LYS SER ILE ASP GLY GLN GLN THR ILE ILE ALA SEQRES 13 A 286 CYS ILE GLU SER HIS GLN PHE GLN PRO LYS ASN PHE TRP SEQRES 14 A 286 ASN GLY ARG TRP ARG SER GLU TRP LYS PHE THR ILE THR SEQRES 15 A 286 PRO PRO THR ALA GLN VAL ALA ALA VAL LEU LYS ILE GLN SEQRES 16 A 286 VAL HIS TYR TYR GLU ASP GLY ASN VAL GLN LEU VAL SER SEQRES 17 A 286 HIS LYS ASP ILE GLN ASP SER VAL GLN VAL SER SER ASP SEQRES 18 A 286 VAL GLN THR ALA LYS GLU PHE ILE LYS ILE ILE GLU ASN SEQRES 19 A 286 ALA GLU ASN GLU TYR GLN THR ALA ILE SER GLU ASN TYR SEQRES 20 A 286 GLN THR MET SER ASP THR THR PHE LYS ALA LEU ARG ARG SEQRES 21 A 286 GLN LEU PRO VAL THR ARG THR LYS ILE ASP TRP ASN LYS SEQRES 22 A 286 ILE LEU SER TYR LYS ILE GLY LYS GLU MET GLN ASN ALA SEQRES 1 B 244 MET SER ASP GLN GLN LEU ASP CYS ALA LEU ASP LEU MET SEQRES 2 B 244 ARG ARG LEU PRO PRO GLN GLN ILE GLU LYS ASN LEU SER SEQRES 3 B 244 ASP LEU ILE ASP LEU VAL PRO SER LEU CYS GLU ASP LEU SEQRES 4 B 244 LEU SER SER VAL ASP GLN PRO LEU LYS ILE ALA ARG ASP SEQRES 5 B 244 LYS VAL VAL GLY LYS ASP TYR LEU LEU CYS ASP TYR ASN SEQRES 6 B 244 ARG ASP GLY ASP SER TYR ARG SER PRO TRP SER ASN LYS SEQRES 7 B 244 TYR ASP PRO PRO LEU GLU ASP GLY ALA MET PRO SER ALA SEQRES 8 B 244 ARG LEU ARG LYS LEU GLU VAL GLU ALA ASN ASN ALA PHE SEQRES 9 B 244 ASP GLN TYR ARG ASP LEU TYR PHE GLU GLY GLY VAL SER SEQRES 10 B 244 SER VAL TYR LEU TRP ASP LEU ASP HIS GLY PHE ALA GLY SEQRES 11 B 244 VAL ILE LEU ILE LYS LYS ALA GLY ASP GLY SER LYS LYS SEQRES 12 B 244 ILE LYS GLY CYS TRP ASP SER ILE HIS VAL VAL GLU VAL SEQRES 13 B 244 GLN GLU LYS SER SER GLY ARG THR ALA HIS TYR LYS LEU SEQRES 14 B 244 THR SER THR VAL MET LEU TRP LEU GLN THR ASN LYS THR SEQRES 15 B 244 GLY SER GLY THR MET ASN LEU GLY GLY SER LEU THR ARG SEQRES 16 B 244 GLN MET GLU LYS ASP GLU THR VAL SER ASP SER SER PRO SEQRES 17 B 244 HIS ILE ALA ASN ILE GLY ARG LEU VAL GLU ASP MET GLU SEQRES 18 B 244 ASN LYS ILE ARG SER THR LEU ASN GLU ILE TYR PHE GLY SEQRES 19 B 244 LYS THR LYS ASP ILE VAL ASN GLY LEU ARG SEQRES 1 C 23 SER TYR LEU ALA HIS PRO THR ARG ASP ARG ALA LYS ILE SEQRES 2 C 23 GLN HIS SER ARG ARG PRO PRO THR ARG GLY HET MES A 287 12 HET MES A 288 24 HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID FORMUL 4 MES 2(C6 H13 N O4 S) FORMUL 6 HOH *379(H2 O) HELIX 1 1 SER A 9 HIS A 23 1 15 HELIX 2 2 GLU A 28 ASN A 41 1 14 HELIX 3 3 ASN A 42 ALA A 50 1 9 HELIX 4 4 ALA A 50 GLN A 61 1 12 HELIX 5 5 THR A 77 HIS A 79 5 3 HELIX 6 6 LEU A 117 TYR A 136 1 20 HELIX 7 7 PRO A 165 ASN A 167 5 3 HELIX 8 8 SER A 220 THR A 253 1 34 HELIX 9 9 THR A 253 ARG A 259 1 7 HELIX 10 10 ASP A 270 SER A 276 1 7 HELIX 11 11 GLN B 4 LEU B 16 1 13 HELIX 12 12 PRO B 17 GLN B 19 5 3 HELIX 13 13 GLN B 20 VAL B 32 1 13 HELIX 14 14 LEU B 35 VAL B 43 1 9 HELIX 15 15 CYS B 62 TYR B 64 5 3 HELIX 16 16 SER B 90 GLU B 113 1 24 HELIX 17 17 PRO B 208 GLY B 234 1 27 HELIX 18 18 GLY B 234 ARG B 244 1 11 HELIX 19 19 HIS C 152 ASP C 156 5 5 SHEET 1 A 2 PRO A 64 VAL A 65 0 SHEET 2 A 2 VAL A 74 LEU A 75 -1 O VAL A 74 N VAL A 65 SHEET 1 B 4 ASP A 81 GLY A 83 0 SHEET 2 B 4 ARG A 86 ASP A 89 -1 O ARG A 86 N GLY A 83 SHEET 3 B 4 ILE A 94 ASP A 99 -1 O ILE A 94 N ASP A 89 SHEET 4 B 4 GLU A 104 PRO A 110 -1 O GLN A 109 N SER A 95 SHEET 1 C10 PHE A 140 SER A 147 0 SHEET 2 C10 GLN A 152 GLN A 164 -1 O THR A 153 N LYS A 146 SHEET 3 C10 TRP A 169 THR A 180 -1 O TRP A 173 N SER A 160 SHEET 4 C10 THR A 185 TYR A 198 -1 O ALA A 189 N LYS A 178 SHEET 5 C10 GLY A 202 GLN A 217 -1 O VAL A 204 N TYR A 198 SHEET 6 C10 GLY B 185 THR B 202 -1 O SER B 192 N ASN A 203 SHEET 7 C10 THR B 164 LYS B 181 -1 N LEU B 169 O MET B 197 SHEET 8 C10 ILE B 144 GLU B 158 -1 N LYS B 145 O GLN B 178 SHEET 9 C10 GLY B 127 ALA B 137 -1 N PHE B 128 O VAL B 156 SHEET 10 C10 VAL B 116 LEU B 124 -1 N SER B 118 O LEU B 133 SHEET 1 D 2 LYS B 48 ASP B 52 0 SHEET 2 D 2 LYS B 57 LEU B 61 -1 O LEU B 61 N LYS B 48 SHEET 1 E 3 ARG B 66 ASP B 67 0 SHEET 2 E 3 SER B 70 ARG B 72 -1 O SER B 70 N ASP B 67 SHEET 3 E 3 TYR B 79 ASP B 80 -1 O ASP B 80 N TYR B 71 CISPEP 1 PRO A 183 PRO A 184 0 3.57 CISPEP 2 ASP B 80 PRO B 81 0 0.82 CISPEP 3 SER B 161 GLY B 162 0 -6.72 CISPEP 4 THR C 168 ARG C 169 0 6.52 SITE 1 AC1 10 PHE A 168 GLU A 200 ASP A 201 HOH A 310 SITE 2 AC1 10 HOH A 382 HOH A 393 ARG B 14 ARG B 195 SITE 3 AC1 10 LEU C 150 ALA C 151 SITE 1 AC2 9 ARG A 7 LEU A 82 ARG A 86 SER A 95 SITE 2 AC2 9 GLN A 109 HOH A 472 LYS B 143 HOH B 344 SITE 3 AC2 9 HOH B 350 CRYST1 57.315 66.298 136.666 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017447 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015083 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007317 0.00000 MASTER 329 0 2 19 21 0 6 6 0 0 0 43 END